AFMD实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:32):
Our systems believe the stock currently is undervalued by 15.58% compare to its pairs and should correct upwards.

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe...

Stats
今日成交量	210 537
平均成交量	700 296
市值	85.35M
EPS	€-1.350 ( Q4 \| 2024-03-28 )
下一个收益日期	( €-1.000 ) 2024-08-08
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.840 (Sector) 42.63 (Industry) 24.32
ATR14	€0.0300 (0.54%)

AADI -3.24%

ABCL 1.46%

ABCM 0.04%

ABEO -2.61%

ABIO -3.08%

ABOS 0.70%

ABSI 1.87%

ABUS -1.80%

ABVX -1.50%

ACAD -0.51%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL 1.59%

ACHV -1.29%

ACIU -0.75%

ACLX 0.80%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.05%

ADGI 0.87%

ADIL 1.75%

ADMA -2.09%

ADPT 0.15%

ADTX -2.38%

ADVM -3.62%

ADXN -1.60%

AEON -2.94%

AEZS -2.49%

AFMD -2.01%

AGEN -1.82%

AGIO -2.39%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.57%

AKRO -3.30%

AKTX 1.45%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.88%

ALGS -0.74%

ALKS 0.33%

ALLK -9.70%

ALLO -5.63%

ALLR -0.48%

ALNA 3.16%

ALNY 2.43%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.25%

ALVR 2.60%

ALXN 0.00%

ALXO -13.24%

ALZN 5.27%

AMRN -1.68%

AMTI -3.13%

ANAB 1.45%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX 0.76%

ANPC -3.15%

APGE -0.07%

APGN 8.48%

APGNW 30.65%

APLM -2.22%

APLS 0.29%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -4.80%

ARDS -14.23%

ARDX 0.25%

ARGX -0.91%

ARNA 0.00%

ARPO -0.90%

ARQT -0.68%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.07%

ARWR -0.71%

ASLN -3.83%

ASMB -5.81%

ASND -1.74%

ATAI -2.22%

ATHA 5.02%

ATHE 0.56%

ATHX -33.50%

ATNF 4.29%

ATOS 2.43%

ATRA -1.29%

ATXI -2.78%

ATXS -0.34%

AUPH -0.99%

AURA 2.79%

AUTL -1.72%

AVBP -1.89%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.48%

AVTX -1.25%

AVXL -3.98%

AXLA 0.00%

AXSM -1.08%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.64%

BCAB 5.56%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.36%

BCRX 0.33%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.80%

BDRX -4.62%

BDTX -1.49%

BEAM 1.03%

BFRA -2.91%

BGNE -2.78%

BIOR -6.17%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.47%

BMEA -11.04%

BMRN 0.07%

BNOX 6.22%

BNTC -0.42%

BNTX -1.62%

BOLD -12.19%

BOLT -0.05%

BPMC -1.14%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 24.25%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.66%

CADL -2.12%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.52%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.78%

CCCC -6.05%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -4.84%

CDTTW -39.60%

CDTX -1.31%

CDXC 1.03%

CDXS 7.59%

CELC -4.21%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -3.67%

CEROW -21.56%

CFRX -27.95%

CGEM -2.98%

CGEN -3.31%

CGON -1.40%

CGTX -3.43%

CHMA -6.00%

CHRS 1.89%

CINC 0.00%

CING -2.73%

CINGW 34.95%

CKPT -3.83%

CLBS -16.75%

CLDX -1.22%

CLGN 0.34%

CLLS -4.15%

CLNN 0.00%

CLNNW 0.00%

CLRB 6.30%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.41%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.48%

CNCE 0.00%

CNSP -35.92%

CNST 0.00%

CNTA -0.28%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -3.37%

CORT 2.80%

COYA -1.46%

CPRX -1.12%

CRBP -3.49%

CRBU -6.53%

CRDF -0.89%

CRGX -0.07%

CRIS -1.72%

CRNX -5.93%

CRSP 0.68%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -4.12%

CTNM -2.21%

CTXR 2.61%

CUE 5.84%

CVAC -5.37%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.07%

CYTO -1.82%

DARE 4.02%

DAWN -1.04%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.93%

DNLI -1.38%

DNTH -10.07%

DOMH 2.43%

DRMA -4.04%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.87%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.49%

EDSA 3.49%

EFTR 5.11%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -6.64%

ELOX -5.38%

ELTX -4.26%

ELVN -4.15%

ELYM 2.23%

ENGN -1.42%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 2.24%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.82%

ETON 1.83%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.40%

EXAI -1.13%

EXEL -0.02%

EYEG -0.69%

EYEN 1.41%

EYPT 0.36%

FATE -10.22%

FBIO 0.89%

FBIOP -0.37%

FBLG -15.40%

FBRX -0.02%

FDMT -3.43%

FENC -1.29%

FGEN -7.69%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.27%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.40%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.64%

GHRS -2.30%

GLMD -5.00%

GLPG -2.11%

GLSI 1.43%

GLTO -2.16%

GLUE -3.17%

GLYC -10.12%

GMAB -0.66%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX -0.22%

GNPX 1.47%

GNTA 3.94%

GOSS -10.71%

GOVX 0.00%

GOVXW -49.04%

GPCR -7.25%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.48%

GRTX 5.14%

GTHX 0.68%

GUTS -4.39%

GXGXW 41.67%

GYRE -8.82%

HALO -1.34%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.15%

HOOK 2.33%

HOTH -3.51%

HOWL -1.50%

HRMY 2.03%

HRTX 4.26%

HSTO 0.00%

HUMA 0.57%

HUMAW -0.01%

IBRX -4.13%

ICCC -1.55%

ICPT 0.21%

ICU 19.34%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.80%

IFRX -1.85%

IGMS -0.51%

IKNA 1.19%

IKT -0.35%

IMAB 2.33%

IMCR -2.88%

IMGN 0.02%

IMGO 0.00%

IMMP 3.99%

IMMX -8.19%

IMNM 0.52%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.58%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.91%

INAB -0.01%

INBX 0.53%

INCY -1.32%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.49%

INMB 1.82%

INO -1.37%

INSM -1.45%

INTS -2.75%

INVA 0.55%

INZY 0.80%

IOBT -10.34%

IONS 0.96%

IOVA -3.43%

IPA -0.49%

IPHA 5.58%

IPSC -2.54%

IRON -1.77%

ISEE 0.38%

ITOS -1.68%

ITRM 1.67%

IVA 6.96%

IVVD -2.89%

JAGX 1.18%

JANX -3.93%

JAZZ -0.62%

JNCE 0.00%

JSPR -5.53%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.80%

KDNY 0.22%

KMPH -0.34%

KNSA -2.08%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.07%

KRRO -8.11%

KRTX 0.03%

KRYS -0.37%

KTRA 9.23%

KTTA -6.79%

KTTAW 0.92%

KURA -0.24%

KYMR -2.95%

KYTX -3.88%

KZIA 2.65%

KZR -0.85%

LABP 0.57%

LBPH -1.75%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.75%

LENZ -5.09%

LEXX -0.77%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.61%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.39%

LPCN -1.86%

LPTX -2.75%

LQDA -0.08%

LRMR -2.06%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.08%

LXRX -2.06%

LYEL -36.32%

LYRA 1.16%

MACK 0.10%

MBIO -8.92%

MBRX -1.72%

MCRB 2.46%

MDGL -1.29%

MDNA -13.16%

MDWD -0.14%

MDXG -2.58%

MEIP 1.40%

MESO -1.26%

MGNX -2.10%

MGTA -7.74%

MGTX -3.61%

MGX -4.02%

MIRM -1.30%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.25%

MLYS -7.53%

MNKD 0.38%

MNMD 0.14%

MNOV 2.11%

MNPR -8.52%

MOLN 2.46%

MOR 1.20%

MORF -3.31%

MREO -2.86%

MRKR 2.57%

MRNA -6.04%

MRNS -4.40%

MRSN -2.14%

MRTX -0.17%

MRUS 0.21%

MRVI -1.16%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 7.08%

NAMS 3.32%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 1.84%

NGM -1.28%

NGNE -1.49%

NKGN 10.08%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.90%

NLSP 5.88%

NLSPW 26.67%

NMRA -2.86%

NMTR -42.97%

NOVN -24.84%

NRBO 7.04%

NRIX -2.31%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.72%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.99%

NTEC -12.45%

NTHI 0.00%

NTLA -6.73%

NTRBW -31.07%

NUVL -1.89%

NVAX -2.14%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.32%

OABIW -10.06%

OBIO -2.92%

OBSV 0.00%

OCEA 0.00%

OCGN 2.12%

OCS -1.00%

OCUL 0.15%

OCUP 1.30%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.16%

OMGA 5.64%

ONCO 4.04%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.99%

ONTX -0.47%

ONVO 1.32%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.42%

ORMP 17.83%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.23%

OVID 1.43%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.18%

PCSA 0.00%

PCVX -0.34%

PDSB -3.16%

PEPG 1.37%

PGEN -2.40%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 7.39%

PMN 0.72%

PMVP -0.89%

PNT 0.16%

PPBT -6.35%

PRAX 3.14%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.41%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.46%

PSTX -1.16%

PTCT -0.46%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 0.33%

QLGN -3.00%

QNCX 5.70%

QNRX -1.14%

QSI -11.97%

QSIAW -3.13%

QTTB -3.45%

QURE -0.78%

RAIN -1.63%

RANI 6.42%

RAPT -1.30%

RARE 1.54%

RCKT -8.70%

REGN 0.29%

RENB -3.11%

REPL -2.49%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 5.00%

RGLS -6.56%

RGNX -5.88%

RIGL -3.29%

RLAY -3.86%

RLMD 0.35%

RLYB -1.34%

RNA 0.62%

RNAC -2.94%

RNAZ -1.92%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.93%

RPRX 0.28%

RPTX -0.29%

RUBY 2.70%

RVLP -32.05%

RVMD -0.93%

RVMDW -30.00%

RVNC 0.21%

RVPH -1.98%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.10%

RYTM -5.59%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -11.81%

SAGE 1.24%

SANA -3.87%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.05%

SCPS 0.00%

SEEL -4.08%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.38%

SGMT -2.42%

SGTX -2.56%

SIOX 22.63%

SLDB -9.14%

SLGL 4.12%

SLN -4.57%

SLNO -4.34%

SLRX 5.27%

SLS -1.71%

SMMT -1.49%

SNDX 1.18%

SNGX -4.91%

SNPX -4.39%

SONN 0.00%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.98%

SRRA 0.00%

SRRK -2.11%

SRZN -2.45%

STAB 0.00%

STOK -5.52%

STRO -3.34%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -8.30%

SWTX -0.19%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.62%

TARS 0.39%

TBPH 0.54%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.45%

TECH -0.08%

TENX 1.91%

TERN -8.55%

TFFP -5.33%

TGTX -4.38%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.83%

TNXP -5.65%

TNYA -4.73%

TPST 5.24%

TRDA -4.06%

TRVI 2.30%

TRVN 4.12%

TSHA -22.76%

TSVT -3.46%

TTNP -7.66%

TVTX 1.75%

TYRA -8.54%

UBX -2.84%

UNCY -3.94%

URGN -1.15%

UTHR 0.56%

VACC 11.36%

VALN -4.07%

VAXX 115.63%

VBIV 0.33%

VBLT -8.77%

VCEL 0.96%

VCNX 10.35%

VCYT -1.61%

VERA -4.20%

VERU 0.98%

VERV -2.96%

VIGL 4.84%

VINC 2.28%

VIR 0.98%

VIRI -1.73%

VIRX 3.15%

VKTX -1.42%

VLON -13.04%

VNDA -3.42%

VOR -1.61%

VRCA 0.07%

VRDN -4.70%

VRNA -0.47%

VRPX 0.38%

VRTX 0.28%

VSTM -1.53%

VTGN -1.81%

VTVT -2.97%

VTYX -2.08%

VXRT -4.88%

VYGR -0.26%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.39%

XBIO 1.03%

XBIT -2.05%

XCUR 3.55%

XENE -0.97%

XERS 2.62%

XFOR 4.17%

XLO 3.88%

XLRN 0.00%

XNCR 0.40%

XOMA -3.22%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.80%

ZNTL -2.14%

ZSAN 0.00%

相关性 (AI algo v.1.1b): Undervalued: 15.58% €6.48 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: -0.05 (neutral)

短: -0.09 (neutral)

Signal:(49.377) Neutral

Affimed NV 相关性

10 最正相关
OZEM	1
ENTO	0.817

10 最负相关
BOTT	-0.917
OPTZ	-0.887
GECCI	-0.859
MTEN	-0.844
CCSB	-0.838
AILEW	-0.804

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Affimed NV 相关性 - 货币/商品

-0.41
( neutral )

0.60
( weak )

0.00
( neutral )

-0.49
( neutral )

0.00
( neutral )

0.09
( neutral )

Affimed NV 财务报表

Annual	2023
营收:	€8.28M
毛利润:	€8.28M (100.00 %)
EPS:	€-7.09

FY	2023
营收:	€8.28M
毛利润:	€8.28M (100.00 %)
EPS:	€-7.09

FY	2022
营收:	€41.35M
毛利润:	€41.35M (100.00 %)
EPS:	€-0.600

FY	2021
营收:	€40.37M
毛利润:	€0.00 (0.00 %)
EPS:	€-0.480

Financial Reports:

No articles found.

Affimed NV Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Affimed NV

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.